20 results
424B3
PRTG
Portage Biotech Inc
28 Feb 24
Prospectus supplement
5:19pm
in a liposome with a six-member carbon head structure that has been shown to activate both human and murine iNKT cells, resulting in DC maturation
6-K
EX-99.2
PRTG
Portage Biotech Inc
28 Feb 24
Current report (foreign)
5:17pm
.
PORT-2 (IMM60)
PORT-2 is an iNKT cell engager formulated in a liposome with a six-member carbon head structure that has been shown to activate both
424B3
PRTG
Portage Biotech Inc
28 Nov 23
Prospectus supplement
4:03pm
intellectual property and know-how.
PORT-2 (IMM60)
PORT-2 is an iNKT cell engager formulated in a liposome with a six-member carbon head structure
6-K
EX-99.2
PRTG
Portage Biotech Inc
28 Nov 23
Current report (foreign)
4:01pm
cell engager formulated in a liposome with a six-member carbon head structure that has been shown to activate both human and murine iNKT cells
424B5
PRTG
Portage Biotech Inc
2 Oct 23
Prospectus supplement for primary offering
6:01pm
Institute's intellectual property and know-how.
PORT 2 (IMM60)
PORT-2 is an iNKT cell activator/agonist formulated in a liposome with a 6-member carbon
6-K
EX-99.2
s7odb
29 Aug 23
Current report (foreign)
4:01pm
6-K
EX-99.2
3gsst4yz6ms40i
29 Nov 22
Current report (foreign)
4:58pm
6-K
EX-99.2
kx4d2dm b1l3iim2n6b
29 Aug 22
Current report (foreign)
4:00pm
6-K
EX-99.2
heob1r5
25 Feb 22
Current report (foreign)
5:29pm
6-K
EX-99.2
8p7r1dq14h
23 Nov 21
Current report (foreign)
4:30pm
6-K
EX-99.2
oibhv1s9ssp0as54a4h1
30 Aug 21
Current report (foreign)
5:21pm
SUPPL
uf72opi9tf7xmpim0
24 Jun 21
Supplemental materials (foreign)
5:27pm
SUPPL
tq118yf7nn42s9
23 Jun 21
Supplemental materials (foreign)
4:01pm
424B2
e3jzik5s56f7j6dgg99f
8 Mar 21
Prospectus for primary offering
5:00pm
6-K
EX-99.2
m41oxiv54mmvh qs
1 Mar 21
Condensed Consolidated Interim Financial Statements
4:23pm
F-3
piifs45whk v9
24 Feb 21
Shelf registration (foreign)
5:22pm
- Prev
- 1
- Next